| |
|
|
|
Matinas Biopharma Hl  
|
|
0.8639 -0.035 (-0.04%) |
10-20 16:00 |
|
Open: |
0.9 |
Pre close: |
0.8993 |
Target:
|
1.08
|
|
High: |
0.91 |
Low: |
0.8354 |
Resistance:
|
0.93
1.08
|
|
Volume: |
1,666,074 |
Market Cap: |
172M |
Support:
|
0.81
 0.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.89
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
0.83 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.81 |
Stochastic Oscillator |
%K(14,3):
|
80.99 |
|
MA(250): |
0.99 |
%D(3): |
81.61 |
|
Average Volume(K) |
3-Month: |
216856
|
52-Week |
High:
|
2.49 |
|
10-Days: |
160949 |
Low: |
0.49 |
|
RSI |
RSI(14):
|
61.30 |
Change(%): |
23.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.121 |
Return on Equity (ttm) |
-36.4 |
Shares Out. (M) |
198.95 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-22.0 |
Shares Float (M) |
162.10 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.55 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.78 |
|
Forward EPS |
-0.150 |
Gross Profit (p.s.) |
-0.056 |
Shares Short (K) |
16300 |
|
Book Value (p.s.) |
0.350 |
EBITDA (p.s.) |
-0.111 |
P/E |
-7.26 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.81 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.28 |
P/CF |
-10.40 |
|
|
|
|
|
|
